跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 17,367 条关于
“Xpert HCV”
全部
17,367
临床试验
15,885
药物
806
机构
24
资讯
652
去年
Point-of-Care Hepatitis C Test Expedites Diagnosis in High-Risk Settings
去年
Atea's Phase 2 Hepatitis C Regimen Shows High Efficacy, Phase 3 Planned for 2025
去年
Nontargeted HCV Screening in Emergency Departments Identifies 34% More New Infections Than Risk-Based Approach
去年
Study Shows DAA Therapy Matches Interferon in Reducing Liver Cancer Risk for HCV Patients
10个月前
Atea Pharmaceuticals Advances HCV Phase 3 Program with New Dual Mechanism Data and Expands Pipeline to Hepatitis E
去年
Cepheid Receives Health Canada Approval for Next-Generation HIV Viral Load Test
2个月前
Poland Expands HCV Treatment to Children as Real-World Data Confirm High DAA Efficacy in Pediatric Patients
3个月前
Atea Pharmaceuticals Advances Antiviral Pipeline with Promising Drug-Drug Interaction Data and First-in-Class HEV Candidate
9个月前
Atea Pharmaceuticals Completes Enrollment in Phase 3 Hepatitis C Trial with Novel Drug Combination
去年
InBrain Pharma Secures €1.8 Million to Industrialize Anaerobic Dopamine Production for Advanced Parkinson's Disease
第 1 页,共 66 页
上一页
下一页